Burhan Khan, Consultant Respiratory Physician, Darent Valley Hospital, Dartford and Gravesham NHS Trust, Dartford, Kent, UK
Richard Leach, Consultant Respiratory Physicians, Guy's and St Thomas' NHS Foundation Trust, London, UK
A 64-year-old man with long-standing COPD and progressive breathlessness was referred for review of his clinical management. His exercise tolerance was limited to 50 metres on the flat or a flight of stairs.
Neil D. Ritchie, Clinical Lecturer in Infectious Diseases, Medical Faculty, University of Glasgow, Glasgow, UK
A 43-year-old Zimbabwean woman presented with headache and meningism of several weeks' duration.
The current update addresses issues around decision-making and referral thresholds for surgery, and..
The objective of this guideline is to provide healthcare professionals with clear guidance on the..
After completing this module you should know the common causes of mucocutaneous lesions in patients with HIV infection. You should know how to recognise such lesions and, where appropriate, how...
This activity is intended for allergists and other physicians with an interest in allergic diseases. The goal of this activity is to discuss the management of allergic rhinoconjunctivitis and other...
This activity is intended for allergists and other physicians with an interest in allergic diseases. The goal of this activity is to discuss the risks and benefits of allergen immunotherapy...
The purpose of this study is to demonstrate the superiority of MD1003 over placebo in the visual improvement of patients suffering from chronic visual loss resulting from multiple sclerosis related optic neuritis.
Efficacy and Safety Study of Prolonged-Release Fampridine in Subjects With Multiple Sclerosis (ENHANCE)18-08-2014
The primary objective is to determine whether prolonged-release fampridine (10 mg twice daily) has a clinically meaningful effect on patient-reported walking ability over a 24-week study period.